Anavo Therapeutics BV

Biotechnology ResearchSouth Holland, Netherlands11-50 Employees

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. 

We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.

Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.

Sign up for free to view info

Email Format Employee directory